Real-world analysis of outcomes of first- line chemo-immunotherapy in patients with extensive disease small cell lung cancer (ED-SCLC)

被引：0
|
作者：
Zellweger, N. [1 ]
Schmid, S. [2 ]
Bertschinger, M. [3 ]
Waibel, C. [4 ]
Cerciello, F.
Frosch, P. [5 ]
Mark, M. [6 ]
Bettini, A. [7 ]
Hauptle, P. [8 ]
Blum, V. [9 ]
Litke, T. [10 ]
Fruh, M. [11 ]
Mauti, L. [3 ]
Rothschild, S. [1 ]
机构：
[1] Univ Basel Hosp, Med Oncol, Basel, Switzerland
[2] Univ Hosp Bern, Med Oncol, Bern, Switzerland
[3] Cantonal Hosp Winterthur, Med Oncol, Winterthur, Switzerland
[4] Cantonal Hosp Baden, Oncol Hematol, Baden, Switzerland
[5] Oncol Inst Southern Switzerland, Med Oncol, Locarno, Switzerland
[6] Cantonal Hosp Graubunden, Oncol Hematol, Chur, Switzerland
[7] HFR Fribourg Cantonal Hosp, Med Oncol, Fribourg, Switzerland
[8] Cantonal Hosp Baselland, Oncol Hematol, Liestal, Switzerland
[9] Cantonal Hosp Lucerne, Med Oncol, Luzern, Switzerland
[10] Univ Basel Hosp, Clin Trial Unit, Basel, Switzerland
[11] Cantonal Hosp St Gallen, Oncol Hematol, St Gallen, Switzerland
来源：
SWISS MEDICAL WEEKLY | 2022年 / 152卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
122
引用
收藏
页码：47S / 48S
页数：2
相关论文
共 50 条
  • [1] Real-world analysis of outcomes of first-line chemo-immunotherapy in patients with extensive disease small cell lung cancer (ED-SCLC)
    Zellweger, N. M.
    Schmid, S.
    Bertschinger, M.
    Waibel, C.
    Cerciello, F. W. F.
    Froesch, P. R.
    Mark, M. T.
    Bettini, A.
    Hauptle, P.
    Blum, V.
    Litke, T.
    Helfenstein, F.
    Frueh, M.
    Mauti, L. A.
    Rothschild, S. I.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S1251 - S1251
  • [2] Combined chemo-immunotherapy as first-line treatment in patients with advanced/metastatic small cell lung cancer ("extensive disease") - a real-world, multicenter analysis
    Zellweger, N.
    Schmid, S.
    Bertschinger, M.
    Waibel, C.
    Cerciello, F.
    Froesch, P.
    Mark, M.
    Bettini, A.
    Hauptle, P.
    Blum, V
    Litke, T.
    Helfenstein, F.
    Fruh, M.
    Mauti, L.
    Rothschild, S.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 207 - 207
  • [3] Real-world treatment patterns and outcomes of patients with extensive disease small cell lung cancer (ED SCLC)
    Cramer-van der Welle, Christine
    Schramel, Franz M. N. H.
    Van Leeuwen, Arvid S.
    Klungel, Olaf H.
    Groen, Harry J. M.
    Van de Garde, Ewoudt M. W.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [4] Radiochemotherapy in Extensive Disease Small Cell Lung Cancer ED-SCLC
    Jeremic, Branislav
    Casas, Francesc
    Wang, Luhua
    Perin, Branislav
    [J]. CONTROVERSIES IN TREATMENT OF LUNG CANCER, 2010, 42 : 180 - 186
  • [5] Real world outcomes of patients treated with first line chemo-immunotherapy (IO) for small cell lung cancer (SCLC): Impact of brain metastases and patterns of subsequent therapy
    Farid, Saira
    Zhao, Songzhu
    Patel, Sandip
    Travis, Kaylee
    Addison, Sarah
    Wei, Lai
    Li, Mingjia
    Palmer, Joshua David
    Beyer, Sasha
    Raval, Raju R.
    Shields, Peter G.
    He, Kai
    Kaufman, Jacob
    Memmott, Regan Michelle
    Alahmadi, Asrar
    Carbone, David Paul
    Otterson, Gregory Alan
    Presley, Carolyn J.
    Owen, Dwight Hall
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] Chemo-Immunotherapy in First Line Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Review and Meta-Analysis
    Sathiyapalan, A.
    Febbraro, M.
    Ellis, P.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S506 - S507
  • [7] Chemo-Immunotherapy in First Line Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Review and Meta-Analysis
    Sathiyapalan, Arani
    Febbraro, Michela
    Pond, Gregory R.
    Ellis, Peter M.
    [J]. CURRENT ONCOLOGY, 2022, 29 (12) : 9046 - 9065
  • [8] Real-World Outcomes of Patients with Advanced Lung Adenocarcinoma Treated with First-Line Chemo-Immunotherapy in Italy
    Perrone, A. Leonetti F.
    Puntoni, M.
    Bordi, P.
    Maglietta, G.
    Carpana, C.
    Gelsomino, F.
    Passiglia, F.
    Genova, C.
    Montrone, M.
    Caliman, E.
    Cerea, G.
    Pasello, G.
    Cecere, F.
    Manzo, A.
    Adamo, V.
    Citarella, F.
    Toschi, L.
    Gelibter, A.
    Rastelli, F.
    Carta, A.
    Guida, A.
    Camerini, A.
    Paoloni, F.
    Bertolini, F.
    Tiseo, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S338 - S339
  • [9] TOTAL COST OF CARE AMONG PATIENTS WITH EXTENSIVE DISEASE SMALL CELL LUNG CANCER (ED-SCLC)
    Danese, M.
    Gleeson, M.
    Lubeck, D.
    Bobiak, S.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A358 - A358
  • [10] Treatment patterns and survival among patients with extensive disease small cell lung cancer (ED-SCLC).
    Danese, Mark D.
    Gleeson, Michelle L.
    Lubeck, Deborah P.
    Korytowsky, Beata
    Bobiak, Sarah
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345